These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3936239)

  • 1. Immunization of marmosets with Trypanosoma cruzi cell surface glycoprotein (GP90).
    Scott MT; Neal RA; Woods NC
    Trans R Soc Trop Med Hyg; 1985; 79(4):451-4. PubMed ID: 3936239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vaccine potential of cell surface glycoproteins from Trypanosoma cruzi.
    Scott MT; Neal RA
    Philos Trans R Soc Lond B Biol Sci; 1984 Nov; 307(1131):63-72. PubMed ID: 6151689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant requirements for protective immunization of mice using a Trypanosoma cruzi 90K cell surface glycoprotein.
    Scott MT; Bahr G; Moddaber F; Afchain D; Chedid L
    Int Arch Allergy Appl Immunol; 1984; 74(4):373-7. PubMed ID: 6429057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
    Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
    Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.
    Bivona AE; Sánchez Alberti A; Matos MN; Cerny N; Cardoso AC; Morales C; González G; Cazorla SI; Malchiodi EL
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006384. PubMed ID: 29601585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination of Callithrix jacchus (Linné, 1758) marmosets with the PF strain of Trypanosoma cruzi.
    Menezes H
    Mem Inst Oswaldo Cruz; 1981; 76(2):131-7. PubMed ID: 6817024
    [No Abstract]   [Full Text] [Related]  

  • 7. Protective immunisation of mice using cell surface glycoprotein from Trypanosoma cruzi.
    Scott MT; Snary D
    Nature; 1979 Nov; 282(5734):73-4. PubMed ID: 116128
    [No Abstract]   [Full Text] [Related]  

  • 8. Trypanosoma cruzi: immune response in mice immunized with parasite antigens.
    Rottenberg ME; Cardoni RL; deTitto EH; Moreno M; Segura EL
    Exp Parasitol; 1988 Feb; 65(1):101-8. PubMed ID: 2892694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prime-boost immunization with cruzipain co-administered with MALP-2 triggers a protective immune response able to decrease parasite burden and tissue injury in an experimental Trypanosoma cruzi infection model.
    Cazorla SI; Frank FM; Becker PD; Corral RS; Guzmán CA; Malchiodi EL
    Vaccine; 2008 Apr; 26(16):1999-2009. PubMed ID: 18342408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization against Trypanosoma cruzi using killed antigens and with saponin as adjuvant.
    Neal RA; Johnson P
    Acta Trop; 1977 Mar; 34(1):87-96. PubMed ID: 16471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell surface glycoproteins of Trypanosoma cruzi: protective immunity in mice and antibody levels in human chagasic sera.
    Snary D
    Trans R Soc Trop Med Hyg; 1983; 77(1):126-9. PubMed ID: 6407157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A DNA-priming protein-boosting regimen significantly improves type 1 immune response but not protective immunity to Trypanosoma cruzi infection in a highly susceptible mouse strain.
    Vasconcelos JR; Boscardin SB; Hiyane MI; Kinoshita SS; Fujimura AE; Rodrigues MM
    Immunol Cell Biol; 2003 Apr; 81(2):121-9. PubMed ID: 12631235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosoma cruzi: protection in mice immunized with 8-methoxypsoralen-inactivated trypomastigotes.
    Andrews NW; Alves MJ; Schumacher RI; Colli W
    Exp Parasitol; 1985 Dec; 60(3):255-62. PubMed ID: 3935472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Driving of Immune Response by Th1 Adjuvants in Immunization of Mice with Trypanosoma cruzi marinkellei Elicits a Controversial Infection Control.
    Nascentes GA; Hernández CG; Rabelo RA; Coelho RF; Morais FR; Marques T; Batista LR; Meira WS; Oliveira CJ; Lages Silva E; Ramírez LE
    Vector Borne Zoonotic Dis; 2016 May; 16(5):317-25. PubMed ID: 26959861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with Trypanosoma cruzi epimastigote antigens incorporated into iscoms protects against lethal challenge in mice.
    Araujo FG; Morein B
    Infect Immun; 1991 Sep; 59(9):2909-14. PubMed ID: 1908826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate.
    Fontanella GH; De Vusser K; Laroy W; Daurelio L; Nocito AL; Revelli S; Contreras R
    Vaccine; 2008 May; 26(19):2322-34. PubMed ID: 18403070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Trypanosoma cruzi TcTASV-C protein subfamily administrated with U-Omp19 promotes a protective response against a lethal challenge in mice.
    Caeiro LD; Masip YE; Rizzi M; Rodríguez ME; Pueblas Castro C; Sánchez DO; Coria ML; Cassataro J; Tekiel V
    Vaccine; 2020 Nov; 38(48):7645-7653. PubMed ID: 33071003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response against Trypanosoma cruzi antigens in Cebus apella monkeys.
    Malchiodi EL; Carbonetto CH; Grana D; Eiguchi de Palmero K; Chiaramonte MG; Falasca CA; Margni RA
    Trop Med Parasitol; 1993 Jun; 44(2):86-90. PubMed ID: 8367672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corynebacterium parvum as an adjuvant for Trypanosoma cruzi epimastigote vaccines: a comparison with saponin and Bordetella pertussis.
    Bomford R; McHardy N
    Parasitology; 1979 Feb; 78(1):77-87. PubMed ID: 216967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of mice against Trypanosoma cruzi: the effect of chemical treatment or immune serum on an epimastigote vaccine.
    McHardy N
    Tropenmed Parasitol; 1978 Jun; 29(2):215-22. PubMed ID: 209592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.